GlassScriptPhysician profile
Jennifer Diabo
NPI 1538195284
$1,650.61
in general payments reported to CMS, 2019-2025
19 companies · $421 in 2025
The $421 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.74 · 2020: $39.27 · 2021: $334 · 2022: $350 · 2023: $93.45 · 2024: $331 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $553.60 | 2021-2023 | Qelbree |
| Sanofi-Aventis U.S. LLC | $285.36 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $192.04 | 2019-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Cranial Technologies, INC | $129.91 | 2023-2025 | Doc Band |
| Becton, Dickinson and Company | $75.00 | 2024-2025 | Bd Introsyte, Powerpicc |
| Sanofi Pasteur INC. | $66.30 | 2021-2024 | |
| Ironshore Pharmaceuticals INC. | $60.84 | 2019-2022 | |
| Seqirus USA INC | $43.48 | 2021-2025 | Flucelvax |
| Collegium Pharmaceutical, INC. | $41.18 | 2025 | Jornay Pm |
| Sentynl Therapeutics, INC. | $35.00 | 2022 | |
| Pfizer INC. | $26.51 | 2019-2024 | |
| Ars Pharmaceuticals Operations, INC. | $25.79 | 2025 | Neffy |
| Bavarian Nordic A/S | $20.11 | 2025 | Vivotif |
| Glaxosmithkline, LLC. | $19.85 | 2020 | |
| Ironwood Pharmaceuticals, INC | $16.62 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $15.68 | 2025 | Ycanth |
| Biogen, INC. | $15.17 | 2024 | Skyclarys |
| Phadia US INC. | $14.84 | 2022 | |
| Shire North American Group INC | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Diabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.